ALK-IN-6 is an orally bioavailable inhibitor of anaplastic lymphoma kinase (ALK,IC50s: 71 nM,18.72 nM,and 36.81 nM for ALK wild,ALK F1196M and ALK F1174L).
TMC310911 is an effective and orally active HIV type-1 protease inhibitor (EC50: ranged from 2.2 nM to 14.2 nM for wild-type HIV-1). TMC310911 has effective activity against a wide spectrum of recombinant HIV-1 isolates.